We use cookies to improve your experience on our site. Please accept the Privacy Policy to continue.

2023 Cerebrovascular/STROKE Program Public Outcomes Report

The Cerebrovascular/Stroke Program at NYC Health + Hospitals/Elmhurst has been recognized for several years in a row for our commitment to providing excellent care to our patients. Elmhurst’s Stroke Program is a recipient of the American Heart Association’s/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus, Target: Stroke Elite Plus, & Target: Type 2 Diabetes Honor Roll awards and the hospital has been certified by The Joint Commission as Thrombectomy Capable Stroke Center, which means we work to provide all our stroke patients with the highest level of care and satisfaction.

We treat about 500 stroke patients every year. We offer variety of treatments for Acute Ischemic Stroke including ‘clot-busting’ thrombolytic therapy and mechanical thrombectomy, which is a treatment that can reopen a blocked blood vessel in a stroke patient using the latest thrombectomy technologies. As of December 2020, the center has inaugurated a state-of-the-art hybrid stroke suite capable of treating the most severe form of strokes. Our team of board-certified stroke neurologists, endovascular neurosurgeons, neurocritical care specialists, emergency medicine physicians, as well as, a nursing staff and a team of physician extenders and technologists trained to the highest calibers to take care of the most complex cerebrovascular patients. Our clinical staff is supported by ancillary staff who provide care and guidance with resources to all our patients during hospitalization and after discharge to the community. 

We use evidenced-based tools to track and measure our success in treating patients and improving patient outcomes. In addition, we have excellent patient outcomes based on the following features of our program:

  • 100% of our stroke patients who present to our Emergency Department and are eligible for thrombolytic treatment – receive this treatment.
  • 100% of patients who are diagnosed with Stroke caused by Large Vessel Occlusion and are eligible for thrombectomy treatment – receive that treatment.
  • 100% of patients who are treated for stroke in our center are evaluated and assessed for rehabilitation and many receive acute rehabilitation in our center.

Elmhurst Hospital and Sinai Affiliated Physicians use highly effective medical devices and novel techniques that result in restoration of blood flow to the brain. 


Thrombolysis in Cerebral Infarction (TICI) Post Treatment Reperfusion Grades for Successful Mechanical Endovascular Reperfusion Therapy

Site: Elmhurst Hospital 

Time Period: January 2023 – October 2023 

Our mission is to serve all New Yorkers regardless of their ability to pay and to be thesafety-net for the uninsured and underserved in New York City. Our mission is to provide quality care for all, without exception.

Our vision is that every patient and family will experience coordinated safe care that exceeds their expectations.

Our aim is to deliver care, treatment and services that are safe, timely, efficient, effective, patient-centered and equitable.

We offer patient-centered care and remain continuously focused on improving the patient experience. We work closely with the Mount Sinai Network to offer novel and unique stroke treatment technologies to our ethnically and economically diverse community.

If you have questions about Cerebrovascular/Stroke Care services at NYC Health + Hospitals/Elmhurst, or to make an appointment, please call 718 334-2792.

Stroke Center Leadership Team

Hazem Shoirah, M.D.
Stroke Program Director

Joseph Farraye, M.D.
Director of Neurology

Zachary Hickman, M.D.
Director of Neurosurgery

Magdalena Zavala, N.P.
Stroke Coordinator

Felipe Ayala, MD
Stroke Faculty

Andrew Lee, MD
Stroke Faculty

Kerstyn Perlman
Research Coordinator